Consistent with its metabolic benefits, the reduced level of adiponectin in the circulation is correlated with a number of human malignancies, including diabetes, inflammation, obesity, fibrosis, and cardiovascular disease. This evidence concerns the gene ADIPOQ and diabetes mellitus.